BlackRock, Inc. 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX | BlackRock Inc. BLK | 1,369,281 3.200% | -1,940,931 (-58.63%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX | BlackRock Inc. BLK | 3,310,212 7.800% | 416,619 (+14.40%) | Filing |
| 2021-01-29 09:57 am Purchase | 2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX | BlackRock Inc. BLK | 2,893,593 7.600% | 313,234 (+12.14%) | Filing |
| 2020-02-05 11:45 am Purchase | 2019-12-31 | 13G | G1 Therapeutics, Inc. GTHX | BlackRock Inc. BLK | 2,580,359 6.900% | 616,645 (+31.40%) | Filing |